Skip to content

Cerevance

  • Platform
  • Tissue Collection
  • Pipeline
  • Team
    • Leadership
    • Advisors
    • Board
    • Investors
  • News
    • Press Releases
    • Media Coverage
  • Contact

News

Press Releases

March 5, 2019

Industry Central Nervous System Specialist Lee Dawson, Ph.D. Joins Cerevance as VP of Neuroscience

October 9, 2018

Cerevance Appoints Ted Hibben as Chief Business Officer

September 25, 2018

Cerevance Announces First-in-Human Dosing of CVN424 for the Treatment of Parkinson’s Disease

February 21, 2018

Cerevance Kicks Off 2018 with Additional $10 Million of Infusions

November 27, 2017

Cerevance Appoints David H. Margolin, M.D., Ph.D., as Senior Vice President of Clinical and Translational Medicine

October 24, 2017

Trailblazer in Molecular Genetics and Neuroscience, Jeremy Nathans, M.D., Ph.D., to Advise Cerevance

October 17, 2017

Cerevance Licenses Human Brain Tissue Profiling Technology from The Rockefeller University

October 12, 2017

Harvard’s Rudolph Tanzi, Ph.D., a Leader in Alzheimer’s Disease Genetics, Joins Cerevance’s Advisory Board

October 5, 2017

Stanford Neuroscientist, Robert Malenka, M.D., Ph.D., to Advise Cerevance

May 3, 2017

Dementia Discovery Fund to Invest $5M in Cerevance to Seek New Treatments for Dementia

  • 1
  • 2
  • 3

View Media Coverage

Cerevance
  • Platform
  • Tissue Collection
  • Pipeline
  • Team
  • News
  • Contact
Copyright Cerevance 2021